What causes xanthomas?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 19, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Causes of Xanthomas

Xanthomas are primarily caused by underlying lipid metabolism disorders, with hypertriglyceridemia being the most common cause of eruptive xanthomas. 1

Primary Genetic Disorders

Severe Hypertriglyceridemia

  • Familial Chylomicronemia Syndrome
    • Autosomal recessive disorders with very high triglycerides (>1000 mg/dL)
    • Caused by mutations in:
      • Lipoprotein lipase (LPL) deficiency
      • Apolipoprotein CII deficiency (cofactor for LPL)
      • Apolipoprotein AV mutations
      • GPIHBP1 mutations 1
    • Presents with eruptive xanthomas, lipemia retinalis, hepatosplenomegaly, and risk of pancreatitis

Familial Hypercholesterolemia

  • Associated with tendinous xanthomas, particularly of the Achilles tendon
  • Characterized by elevated LDL cholesterol levels 2

Familial Combined Hyperlipidemia (FCHL)

  • Multiple lipoprotein abnormalities with elevated apolipoprotein B levels
  • Characterized by increased production of apoB-containing lipoproteins 1, 3

Type III Dysbetalipoproteinemia (Familial)

  • Defective apolipoprotein E (usually apoE2/E2 phenotype)
  • Characterized by palmar xanthomas and tuberous xanthomas
  • Near-equivalent cholesterol and triglyceride values 1

Secondary Causes

Metabolic Disorders

  • Diabetes Mellitus
    • Poorly controlled diabetes leads to hypertriglyceridemia
    • Can cause eruptive xanthomas even as the first presenting symptom 4
    • Increased hepatic VLDL production and defective clearance of chylomicrons 1

Obesity

  • Increases triglyceride levels through:
    • Increased visceral fat exposing liver to higher FFA levels
    • Impaired clearance of triglyceride-rich lipoproteins 1

Lipodystrophy

  • Both inherited and acquired forms (including HIV-associated)
  • Characterized by loss of adipose tissue and hypertriglyceridemia
  • Can lead to eruptive xanthomas and pancreatitis 1

Other Secondary Factors

  • Excessive alcohol consumption
  • Hypothyroidism
  • Medications (estrogens, retinoids, corticosteroids, antiretrovirals)
  • Pregnancy 1

Clinical Presentation by Xanthoma Type

Eruptive Xanthomas

  • Sudden crops of 1-4 mm yellow-orange papules
  • Typically on extensor surfaces and buttocks
  • Associated with severe hypertriglyceridemia (>1000 mg/dL) 5, 6
  • Often the first sign of undiagnosed diabetes or severe hypertriglyceridemia 4

Tendinous Xanthomas

  • Associated with familial hypercholesterolemia
  • Commonly affect Achilles tendon 2, 7

Tuberous Xanthomas

  • Associated with familial hypercholesterolemia and dysbetalipoproteinemia 1, 7

Palmar Xanthomas

  • Characteristic of familial dysbetalipoproteinemia 1, 7

Xanthelasma

  • Yellowish plaques around eyelids
  • May be associated with normal lipid levels in 20-30% of cases 2

Diagnostic Approach

  1. Complete fasting lipid profile

    • Triglycerides, total cholesterol, LDL, HDL
    • Fasting lipid testing is essential for accurate diagnosis 1
  2. Screen for secondary causes

    • Diabetes (HbA1c, fasting glucose)
    • Thyroid function tests
    • Medication review
    • Alcohol consumption assessment 1
  3. Family history assessment

    • Evaluate for familial lipid disorders
    • History of premature cardiovascular disease 1

Management Considerations

  • Primary goal: Treat underlying lipid disorder to reduce morbidity and mortality
  • For severe hypertriglyceridemia (>500 mg/dL), priority is lowering triglycerides to reduce pancreatitis risk 1
  • Lifestyle modifications are foundational for all patients with hypertriglyceridemia 1
  • Referral to a registered dietitian is strongly recommended 1
  • Statins are not recommended specifically for xanthomas in Alagille syndrome but may be appropriate for other hyperlipidemia causes 1

Clinical Pearls

  • Eruptive xanthomas can be misdiagnosed as other skin conditions (e.g., molluscum contagiosum) 5
  • The appearance of xanthomas should prompt immediate evaluation of lipid metabolism disorders
  • Xanthomas often resolve with successful treatment of the underlying metabolic disorder
  • The specific type of xanthoma can provide clues to the underlying lipid disorder 7

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Xanthomata and Xanthelasma Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Eruptive Xanthoma With Dermal Mucin Deposition.

The American Journal of dermatopathology, 2021

Research

Xanthomas: a marker for hyperlipidemias.

Boletin de la Asociacion Medica de Puerto Rico, 2003

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.